Is total community viral load a robust predictive marker of the efficacy of the TasP strategy?

Journal of acquired immune deficiency syndromes (1999)

Volumn 61, Issue 3, 2012, Pages 400-402

  Henard, Sandrine ^a   Jeanmaire, Eliette ^b   Nguyen, Yohan ^b   Yazdanpanah, Yazdan ^b   Cheret, Antoine ^b   Hoen, Bruno ^b   Rey, David ^b   Borel, Alice ^b   Chavanet, Pascal ^b   May, Thierry ^b   Rabaud, Christian ^b   ICONE Group, ^b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; DEMOGRAPHY; DRUG EFFECT; EARLY DIAGNOSIS; FEMALE; FRANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; POISSON DISTRIBUTION; STATISTICS; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; EARLY DIAGNOSIS; FEMALE; FRANCE; HIV INFECTIONS; HUMANS; MALE; POISSON DISTRIBUTION; RESIDENCE CHARACTERISTICS; VIRAL LOAD;

EID: 85027929751     PISSN: None     EISSN: 19447884     Source Type: Journal    
DOI: 10.1097/qai.0b013e318263a111     Document Type: Article

References (0)